Skip to main content
. 2017 Apr 6;110(4):144–152. doi: 10.1177/0141076817696054

Figure 2.

Figure 2.

Boxes demonstrating (a) the effects of cross-sex hormonal medications for trans men and women (whether these are desirable or unwanted will depend on individual patient preference), (b) risks of hormone medications, (c) recommended monitoring if cross-sex hormone medications are prescribed,1,21,25 (d) surgical options for gender reassignment25 and (e) non-surgical and surgical treatment options recommended for funding by the NHS.26